Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Jimerson

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Communications in Psychopharmacology|January 1, 1978
Homovanillic acid in human CSF: comparison of fluorimetry and gas chromatography-mass spectrometryD C Jimerson, E K Gordon, R M Post, et al.
Biological Psychiatry|September 1, 1982
Red cell ouabain-sensitive Na+-K+-adenosine triphosphatase: a state marker in affective disorder inversely related to plasma cortisolJ Nurnberger, D C Jimerson, J R Allen, et al.
Biomedical Mass Spectrometry|June 1, 1981
Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometryD C Jimerson, S P Markey, J A Oliver, et al.
The Psychiatric Clinics of North America|December 1, 1996
Medications in the treatment of eating disordersD C Jimerson, B E Wolfe, A W Brotman, et al.
Brain Research|December 5, 1975
Central noradrenergic function in man: vanillylmandelic acid in CSFD C Jimerson, E K Gordon, R M Post, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Serotonin in human eating disordersD C Jimerson, M D Lesem, A P Hegg, et al.
Archives of General Psychiatry|April 1, 1984
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's diseaseM A Raskind, E R Peskind, J B Halter, et al.
Science (New York, N.Y.)|January 7, 1983
Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycolI J Kopin, E K Gordon, D C Jimerson, et al.
Psychopharmacology|January 1, 1980
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozideR M Post, D C Jimerson, W E Bunney, et al.
Archives of General Psychiatry|September 1, 1988
Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtypeG N Ko, D C Jimerson, R J Wyatt, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Communications in Psychopharmacology|January 1, 1978
Homovanillic acid in human CSF: comparison of fluorimetry and gas chromatography-mass spectrometryD C Jimerson, E K Gordon, R M Post, et al.
Biological Psychiatry|September 1, 1982
Red cell ouabain-sensitive Na+-K+-adenosine triphosphatase: a state marker in affective disorder inversely related to plasma cortisolJ Nurnberger, D C Jimerson, J R Allen, et al.
Biomedical Mass Spectrometry|June 1, 1981
Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometryD C Jimerson, S P Markey, J A Oliver, et al.
The Psychiatric Clinics of North America|December 1, 1996
Medications in the treatment of eating disordersD C Jimerson, B E Wolfe, A W Brotman, et al.
Brain Research|December 5, 1975
Central noradrenergic function in man: vanillylmandelic acid in CSFD C Jimerson, E K Gordon, R M Post, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Serotonin in human eating disordersD C Jimerson, M D Lesem, A P Hegg, et al.
Archives of General Psychiatry|April 1, 1984
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's diseaseM A Raskind, E R Peskind, J B Halter, et al.
Science (New York, N.Y.)|January 7, 1983
Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycolI J Kopin, E K Gordon, D C Jimerson, et al.
Psychopharmacology|January 1, 1980
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozideR M Post, D C Jimerson, W E Bunney, et al.
Archives of General Psychiatry|September 1, 1988
Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtypeG N Ko, D C Jimerson, R J Wyatt, et al.
Pageof 13